Cosmos Health targets 2029 revenue of $200.6 million and net income of $31.0 million

Cosmos Health issued 2029 guidance for revenue of $200.6 million, gross profit of $71.2 million and adjusted EBITDA of $44.2 million, plus net income of $31.0 million, with CosmoFarm expected to support volume growth.